MedPage Today on MSN21h
FDA Expands Guselkumab Approval to Crohn's DiseaseThe FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback